HEADER HYDROLASE 22-JAN-04 1S65 OBSLTE 03-OCT-06 1S65 2IDW TITLE CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A TITLE 2 WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) CAVEAT 1S65 CHIRALITY ERROR AT CB OF LEU B 38 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HIV-1 PROTEASE; COMPND 5 SYNONYM: RETROPEPSIN; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: VIRUS; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS HIV-1 PROTEASE, MUTANT, DIMER, INHIBITOR, UIC-94017 EXPDTA X-RAY DIFFRACTION AUTHOR Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,D.MANNA,A.K.HUSSAIN, AUTHOR 2 S.LESHCHENKO,A.K.GHOSH,J.M.LOUIS,R.W.HARRISON,I.T.WEBER REVDAT 3 03-OCT-06 1S65 1 OBSLTE REVDAT 2 01-MAR-05 1S65 1 JRNL REVDAT 1 22-JUN-04 1S65 0 JRNL AUTH Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,A.K.HUSSAIN, JRNL AUTH 2 S.LESHCHENKO,A.K.GHOSH,J.M.LOUIS,R.W.HARRISON, JRNL AUTH 3 I.T.WEBER JRNL TITL HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 JRNL TITL 2 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR JRNL TITL 3 (UIC-94017) ACTIVE AGAINST MULTI-DRUG-RESISTANT JRNL TITL 4 CLINICAL STRAINS. JRNL REF J.MOL.BIOL. V. 338 341 2004 JRNL REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.117 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.116 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.145 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3715 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 74373 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.110 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.108 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.138 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3351 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 66823 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 127 REMARK 3 SOLVENT ATOMS : 291 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1768.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1624.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 36 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 18427 REMARK 3 NUMBER OF RESTRAINTS : 23862 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.034 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.030 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.085 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.086 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.144 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.059 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.087 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1S65 COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.100 (2007-05-01) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JAN-2004. REMARK 100 THE RCSB ID CODE IS RCSB021415. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-2002 REMARK 200 TEMPERATURE (KELVIN) : 90.0 REMARK 200 PH : 5.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74707 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.19600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DAZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, CITRIC PHOSPHATE, REMARK 280 DMSO, PH 5.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.39500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.96950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.93700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.96950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.39500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.93700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O HOH 1038 O HOH 1211 0.30 REMARK 500 NH2 ARG B 57 O HOH 1073 0.31 REMARK 500 NH1 ARG A 41 O HOH 1117 0.41 REMARK 500 OE1 GLU B 35 O HOH 1193 0.61 REMARK 500 O HOH 1197 O HOH 1262 0.72 REMARK 500 O1 PO4 704 O HOH 1266 0.76 REMARK 500 P PO4 704 O HOH 1266 0.89 REMARK 500 O HOH 1228 O HOH 1261 0.94 REMARK 500 NH1 ARG A 8 O HOH 1267 1.05 REMARK 500 O HOH 1235 O HOH 1242 1.05 REMARK 500 CZ ARG B 57 O HOH 1073 1.07 REMARK 500 O HOH 1063 O HOH 1262 1.08 REMARK 500 CG2 THR A 4 O HOH 1027 1.10 REMARK 500 O HOH 1121 O HOH 1225 1.10 REMARK 500 O HOH 1183 O HOH 1191 1.20 REMARK 500 OD1 ASP A 30 O HOH 1223 1.25 REMARK 500 O ACY 603 O HOH 1230 1.26 REMARK 500 O HOH 1089 O HOH 1192 1.31 REMARK 500 O HOH 1034 O HOH 1039 1.34 REMARK 500 NE2 GLN A 18 O HOH 1245 1.35 REMARK 500 O HOH 1109 O HOH 1174 1.35 REMARK 500 CZ ARG A 41 O HOH 1117 1.37 REMARK 500 O HOH 1040 O HOH 1186 1.39 REMARK 500 O HOH 1143 O HOH 1263 1.44 REMARK 500 O HOH 1195 O HOH 1219 1.46 REMARK 500 O HOH 1081 O HOH 1220 1.49 REMARK 500 O HOH 1105 O HOH 1186 1.49 REMARK 500 C ACY 603 O HOH 1230 1.51 REMARK 500 O HOH 1205 O HOH 1230 1.55 REMARK 500 O HOH 1202 O HOH 1274 1.56 REMARK 500 CL CL 501 O HOH 1163 1.61 REMARK 500 O HOH 1063 O HOH 1197 1.62 REMARK 500 O HOH 1206 O HOH 1272 1.62 REMARK 500 O ACY 602 O HOH 1214 1.65 REMARK 500 O HOH 1202 O HOH 1264 1.65 REMARK 500 NH2 ARG A 8 O HOH 1222 1.66 REMARK 500 O HOH 1175 O HOH 1219 1.70 REMARK 500 O HOH 1264 O HOH 1274 1.71 REMARK 500 CD GLU B 35 O HOH 1193 1.80 REMARK 500 NE2 GLN A 18 O HOH 1160 1.81 REMARK 500 OE2 GLU B 34 O HOH 1250 1.82 REMARK 500 O HOH 1107 O HOH 1189 1.84 REMARK 500 CD GLU B 34 O HOH 1258 1.86 REMARK 500 O HOH 1093 O HOH 1174 1.86 REMARK 500 O2 PO4 704 O HOH 1266 1.89 REMARK 500 O HOH 1106 O HOH 1273 1.89 REMARK 500 O THR A 4 O HOH 1040 1.91 REMARK 500 NZ LYS A 20 O HOH 1269 1.94 REMARK 500 OE1 GLU B 35 O HOH 1107 1.94 REMARK 500 CZ ARG A 8 O HOH 1222 1.95 REMARK 500 O4 PO4 704 O HOH 1266 1.96 REMARK 500 O HOH 1092 O HOH 1232 1.96 REMARK 500 NH1 ARG B 57 O HOH 1073 1.99 REMARK 500 OE2 GLU B 34 O HOH 1258 2.00 REMARK 500 O1 GOL 801 O HOH 1058 2.01 REMARK 500 O HOH 1110 O HOH 1112 2.01 REMARK 500 OXT ACY 603 O HOH 1230 2.02 REMARK 500 O HOH 1196 O HOH 1264 2.02 REMARK 500 CZ ARG A 8 O HOH 1267 2.06 REMARK 500 O HOH 1145 O HOH 1257 2.09 REMARK 500 CG2 THR A 4 O HOH 1273 2.11 REMARK 500 O DMS 901 O HOH 1248 2.11 REMARK 500 O HOH 1050 O HOH 1192 2.11 REMARK 500 NE ARG B 57 O HOH 1073 2.13 REMARK 500 O HOH 1070 O HOH 1104 2.14 REMARK 500 O HOH 1250 O HOH 1258 2.15 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS B 43 CA - CB - CG ANGL. DEV. = 15.2 DEGREES REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S6D RELATED DB: PDB REMARK 900 RELATED ID: 1S6S RELATED DB: PDB DBREF 1S65 A 1 99 UNP P03368 POL_HV1PV 69 167 DBREF 1S65 B 1 99 UNP P03368 POL_HV1PV 69 167 SEQADV 1S65 LYS A 7 UNP P03368 GLN 75 ENGINEERED SEQADV 1S65 ILE A 33 UNP P03368 LEU 101 ENGINEERED SEQADV 1S65 ILE A 63 UNP P03368 LEU 131 ENGINEERED SEQADV 1S65 ALA A 67 UNP P03368 CYS 135 ENGINEERED SEQADV 1S65 ALA A 82 UNP P03368 VAL 150 ENGINEERED SEQADV 1S65 ALA A 95 UNP P03368 CYS 163 ENGINEERED SEQADV 1S65 LYS B 7 UNP P03368 GLN 75 ENGINEERED SEQADV 1S65 ILE B 33 UNP P03368 LEU 101 ENGINEERED SEQADV 1S65 ILE B 63 UNP P03368 LEU 131 ENGINEERED SEQADV 1S65 ALA B 67 UNP P03368 CYS 135 ENGINEERED SEQADV 1S65 ALA B 82 UNP P03368 VAL 150 ENGINEERED SEQADV 1S65 ALA B 95 UNP P03368 CYS 163 ENGINEERED SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE HET CL 501 2 HET PO4 701 5 HET PO4 702 10 HET PO4 703 10 HET PO4 704 5 HET 017 401 87 HET DMS 901 8 HET ACY 601 4 HET ACY 602 4 HET ACY 603 4 HET ACY 604 4 HET ACY 605 4 HET ACY 606 8 HET GOL 801 6 HETNAM CL CHLORIDE ION HETNAM PO4 PHOSPHATE ION HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETNAM DMS DIMETHYL SULFOXIDE HETNAM ACY ACETIC ACID HETNAM GOL GLYCEROL HETSYN 017 TMC114; UIC-94017 FORMUL 3 CL CL 1- FORMUL 4 PO4 4(O4 P 3-) FORMUL 8 017 C27 H37 N3 O7 S FORMUL 9 DMS C2 H6 O S FORMUL 10 ACY 6(C2 H4 O2) FORMUL 16 GOL C3 H8 O3 FORMUL 17 HOH *257(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 96 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45 SHEET 3 B 8 HIS A 69 GLY A 78 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 THR A 31 GLU A 34 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 C 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 CRYST1 50.790 57.874 61.939 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019689 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017279 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016145 0.00000